MercuriM, SherbinoJ, SedranRJ, FrankJR, GafniA, NormanG. 2015. When guidelines don't guide: the effect of patient context on management decisions based on clinical practice guidelines. Acad Med, 90:191–196.
2.
DanielsGH, KoppPA. 2019. Editorial: guidelines are not gospel! Thyroid. [Epub ahead of print]; DOI: 10.1089/thy.2019.0283.
3.
MercuriM, GafniA. 2018. The evolution of GRADE (part 3): a framework built on science or faith?. J Eval Clin Pract, 24:1223–1231.
4.
DjulbegovicB, ReljicT, ElqayamS, CukerA, HozoI, ZhouQ, LiSA, AlexanderP, NieuwlaatR, WierciochW, SchünemannH, GuyattG. 2019. Structured decision-making drives guidelines panels' recommendations “for” but not “against” health interventions. J Clin Epidemiol, 110:23–33.
5.
BekkeringGE, AgoritsasT, LytvynL, HeenAF, FellerM, MoutzouriE, AbdulazeemH, AertgeertsB, BeecherD, BritoJP, FarhoumandPD, Singh OspinaN, RodondiN, van DrielM, WallaceE, SnelM, OkwenPM, SiemieniukR, VandvikPO, KuijpersT, VermandereM. 2019. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ, 365:l2006.
6.
GuyattGH, AgoritsasT, LytvynL, SiemieniukR, VandvikP. 2018. BMJ Rapid Recommendations: creating tools to support a revolution in clinical practice guideline adoption. Can J Gen Intern Med, 14:6–12.
7.
FellerM, SnelM, MoutzouriE, BauerDC, de MontmollinM, AujeskyD, FordI, GusseklooJ, KearneyPM, MooijaartS, QuinnT, StottD, WestendorpR, RodondiN, DekkersOM. 2018. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA, 320:1349–1359.
8.
RodondiN, den ElzenWP, BauerDC, CappolaAR, RazviS, WalshJP, AsvoldBO, IervasiG, ImaizumiM, ColletTH, BremnerA, MaisonneuveP, SgarbiJA, KhawKT, VanderpumpMP, NewmanAB, CornuzJ, FranklynJA, WestendorpRG, VittinghoffE, GusseklooJ; Thyroid Studies Collaboration. 2010. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304:1365–1374.
9.
GencerB, ColletTH, VirginiV, BauerDC, GusseklooJ, CappolaAR, NanchenD, den ElzenWP, BalmerP, LubenRN, IacovielloM, TriggianiV, CornuzJ, NewmanAB, KhawKT, JukemaJW, WestendorpRG, VittinghoffE, AujeskyD, RodondiN; Thyroid Studies Collaboration. 2012. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation, 126:1040–1049.
10.
DíezJJ, IglesiasP. 2004. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab, 89:4890–4897.
11.
HuberG, StaubJJ, MeierC, MitracheC, GuglielmettiM, HuberP, BravermanLE. 2002. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab, 87:3221–3226.
12.
SomwaruLL, RariyCM, ArnoldAM, CappolaAR. 2012. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab, 97:1962–1969.
13.
GarberJR, CobinRH, GharibH, HennesseyJV, KleinI, MechanickJI, Pessah-PollackR, SingerPA, Woeber KA; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism inAdults. 2012. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract, 18:988–1028.
14.
PearceSH, BrabantG, DuntasLH, MonzaniF, PeetersRP, RazviS, WemeauJL. 2013. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J, 2:21528.
15.
JonklaasJ, BiancoAC, BauerAJ, BurmanKD, CappolaAR, CeliFS, CooperDS, KimBW, PeetersRP, RosenthalMS, SawkaAM; American Thyroid Association Task Force on Thyroid Hormone Replacement. 2014. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid, 24:1670–1751.
16.
StottDJ, RodondiN, KearneyPM, FordI, WestendorpRGJ, MooijaartSP, SattarN, AubertCE, AujeskyD, BauerDC, BaumgartnerC, BlumMR, BrowneJP, ByrneS, ColletTH, DekkersOM, den ElzenWPJ, Du PuyRS, EllisG, FellerM, FlorianiC, HendryK, HurleyC, JukemaJW, KeanS, KellyM, KrebsD, LanghorneP, McCarthyG, McCarthyV, McConnachieA, McDadeM, MessowM, O'FlynnA, O'RiordanD, PoortvlietRKE, QuinnTJ, RussellA, SinnottC, SmitJWA, Van DorlandHA, WalshKA, WalshEK, WattT, WilsonR, GusseklooJ; TRUST Study Group. (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med, 376:2534–2544.
17.
WattT, HegedüsL, GroenvoldM, BjornerJB, RasmussenAK, BonnemaSJ, Feldt-RasmussenU. 2010. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol, 162:161–167.
18.
ZhangY, CoelloPA, BrożekJ, WierciochW, Etxeandia-IkobaltzetaI, AklEA, MeerpohlJJ, AlhazzaniW, Carrasco-LabraA, MorganRL, MustafaRA, RivaJJ, MooreA, Yepes-NuñezJJ, Cuello-GarciaC, AlRayeesZ, ManjaV, FalavignaM, NeumannI, Brignardello-PetersenR, SantessoN, RochwergB, DarziA, RojasMX, AdiY, BolligC, WaziryR, SchünemannHJ. 2017. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes, 15:52.
19.
NexøMA, WattT, ClealB, HegedüsL, BonnemaSJ, RasmussenÅK, Feldt-RasmussenU, BjornerJB. 2015. Exploring the experiences of people with hypo- and hyperthyroidism. Qual Health Res, 25:945–953.
20.
MontoriVM, BritoJP, MuradMH. 2013. The Optimal Practice of Evidence-Based Medicine: incorporating Patient Preferences in Practice Guidelines. JAMA, 310:2503–2504.
21.
JonklaasJ, RazviS. 2019. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol, 7:473–483.
